Jiangxi Yintao Pharmaceuticals Co., Ltd.

Jiangxi Yintao Pharmaceutical Co., Ltd., located in Fuzhou, Jiangxi, is a high-tech enterprise integrating drug research, development, production, and sales, with wholly-owned subsidiaries Jiangxi Juwang Pharmaceutical Co., Ltd. and Jiangxi Yintao Trade Co., Ltd., covering a total area of 186,000 square meters. It has 562 employees, including 11 senior engineers and 62 licensed pharmacists, with over 30% professional technical personnel. It has 11 production lines for 8 dosage forms including small-volume injections, capsules, granules, pills, tablets, topical solutions, lotions, and tinctures, with products covering 9 categories and 15 series such as tonics, cardiovascular, antibacterial, gynecology, rheumatism, digestive system, heat-clearing, blood-activating, and health products, with 145 drug approvals, including 26 national new drugs and 22 basic drugs. Main products include Qiangli Dingxian Capsules, Yougui Capsules, Maoluoning Granules, Stephania Tetrandra Glycoside Injection, and Honghua Xiaoyao Granules. In 2023, the company ranked among the top 100 Chinese medicine enterprises in the China Pharmaceutical Market Enterprise Rankings.